Abiopharma

🔍 Hunter Danielle E. (Executive)

Company: Centuri Holdings, Inc. (CTRI)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 16,967 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,967.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 8,837 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,804.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the grant of restricted stock units ("RSUs") pursuant to the Omnibus Incentive Plan of Centuri Holdings, Inc. (the "Issuer") on August 12, 2026 (together, the "2026 RSU Grants"). Each RSU subject to the 2026 RSU Grants is the economic equivalent of one share of the Issuer's common stock and may be settled by delivery of one share of the Issuer's common stock.
• REMARKS: The reporting person's full title is Executive Vice President, Chief Legal & Administrative Officer and Corporate Secretary.